Table 4.

Linear regression analysis for factors possibly associated with 24‐h cPP levels in the total population

Parameter	Univariate analysis			Multivariable analysis
	β	95% CI	p	β	95% CI	p
Age (per year increase)	0.142	−0.009 to 0.292	.064	0.061	−0.052 to 0.175	.287
Female	2.723	−0.370 to 5.815	.084	2.489	0.244 to 4.734	.030
BMI (per kg/m2 increase)	0.182	−0.061 to 0.425	.139	0.139	−0.040 to 0.318	.126
Active smoking	−0.129	−3.845 to 3.588	.945
Diabetes	6.233	3.437 to 9.028	<.001	2.427	0.196 to 4.657	.033
Coronary heart disease	0.869	−3.138 to 4.875	.668
Stroke	4.109	−2.183 to 10.401	.198	4.226	−0.037 to 8.489	.052
Peripheral vascular disease	−1.561	−6.041 to 2.918	.491
Heart failure	0.233	−7.456 to 7.923	.952
Dyslipidemia	4.082	0.768 to 7.396	.016	2.306	−0.135 to 4.746	.064
Antihypertensive treatment	5.685	−5.011 to 16.380	.294
eGFR (per ml/min/1.73 m2 increase)	−0.014	−0.099 to 0.072	.753
24‐h Urine sodium (per mEq/L increase)	0.001	−0.0001 to 0.002	.088	−0.0001	−0.001 to 0.001	.537
24‐h SBP (mmHg)	0.435	0.338 to 0.532	<.001	0.404	0.304 to 0.505	<.001
24‐h DBP (mmHg)	−0.065	−0.266 to 0.137	.527

Statistically significant P values are marked with bold.